Skip to main content

Analgesia for pelvic and perineal cancer pain by intrathecal steroid injection

Buy Article:

$43.00 plus tax (Refund Policy)

Background: 

Corticosteroids are used systemically in patients with advanced cancer to alleviate pain. Intrathecal administration of steroids is rarely performed but analgesic effects of intrathecal steroids have been reported in animal studies. We administered betamethasone intrathecally in three cancer patients with uncontrollable pain. Case report: 

Intrathecal injection of betamethasone (1–4 mg) with saline (total volume = 2 mL) was performed in three patients with advanced pelvic or perineal cancer, in whom pain could not be controlled in spite of various analgesic therapies. After obtaining the patient's informed consent for the procedure, betamethasone was administered intrathecally through the L4/5 intervertebral space. Intrathecal betamethasone produced rapid analgesia within 10 min and subsequent long-lasting analgesia for 5 days or more. Sleep, appetite and activity improved. No adverse effects were observed in any of the patients. Conclusions: 

Intrathecal injection of betamethasone may be a useful approach in some patients with intractable cancer pain.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: betamethasone; cancer pain; corticosteroid; intrathecal injection; perineal cancer; spinal analgesia

Document Type: Research Article

Affiliations: Department of Anesthesiology, Kansai Medical University, Moriguchi, Osaka 570–8506, Japan

Publication date: 2002-02-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more